Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

A high-fat diet caused severe health problems in female macaques but was reversible with a normal diet, while male macaques reacted differently.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The study found no significant link between Helicobacter pylori infection and polycystic ovary syndrome in young females.